Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21716274 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects
Condition: Healthy
Interventions: Drug: CLOPIDOGREL;   Drug: placebo

Indicates status has not been verified in more than two years